Shattuck Labs (STTK) Operating Leases (2022 - 2026)
Shattuck Labs (STTK) reported Operating Leases of $2.0 million for Q1 2026, down 10.11% year-over-year from $2.3 million in Q1 2025, and up 28.6% quarter-over-quarter from $1.6 million in Q4 2025.
Shattuck Labs (STTK) Operating Leases (2022 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 5 years of Operating Leases data on file, last reported at $2.0 million in Q1 2026.
- Operating Leases for Q1 2026 came in at $2.0 million, down 10.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 million (down 10.11% YoY), and the FY2025 annual result was $1.6 million, down 36.79% from the prior year.
- Operating Leases advanced to $2.0 million in Q1 2026 per STTK's latest filing, from $1.6 million in the prior quarter.
- Over five years, Operating Leases peaked at $5.3 million in Q1 2022 and troughed at $1.6 million in Q4 2025.
- A 5-year average of $3.3 million and a median of $3.2 million in 2024 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2023 and 2024: Operating Leases changed 0.0% in 2023, then tumbled 40.36% in 2024.
- A 5-year view of Operating Leases shows it stood at $4.2 million in 2022, then changed by 0.0% to $4.2 million in 2023, then slumped by 40.36% to $2.5 million in 2024, then tumbled by 36.79% to $1.6 million in 2025, then gained by 28.6% to $2.0 million in 2026.
- Business Quant data shows STTK's Operating Leases at $2.0 million in Q1 2026, $1.6 million in Q4 2025, and $1.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.04 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 2.51 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | 2.97 Mn |
| Mar 31, 2024 | 3.19 Mn |
| Dec 31, 2023 | 4.20 Mn |
| Sep 30, 2023 | 3.62 Mn |
| Jun 30, 2023 | 3.82 Mn |
| Mar 31, 2023 | 4.01 Mn |
| Dec 31, 2022 | 4.20 Mn |
| Sep 30, 2022 | 5.07 Mn |
| Jun 30, 2022 | 4.57 Mn |
| Mar 31, 2022 | 5.35 Mn |